Global Tumor Ablation Devices Market, by Technology, Application, End User and by Geography - Trends and Forecast, 2022 - 2028

Global Tumor Ablation Devices Market, by Technology, Application, End User and by Geography - Trends and Forecast, 2022 - 2028

Tumor ablation is a minimally invasive procedure to remove the tumor cells or tissue from the body. Tumor ablation devices are consists of a catheter, which is introduced into the tumor under imaging guidance. Advancements in cryosurgical technology and intraoperative monitoring devices have gained the adoption of tumor ablation devices by the healthcare professionals. As this technology have led to the implementation of high accuracy and precision in treating chronic diseases such as a liver tumor. The use of Microwave Ablation magnetic image-guiding systems has provided an effective adjunct in laparoscopic ablation and helps in providing better support to surgeons and increases clinical patient outcome.
Market Dynamics
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators, etc. Moreover, key players are also indulged in offering various lucrative features to the potential buyers of the ablation devices such as hospitals and clinics that would in turn help them to grow their sales and establish a global market presence. For instance, Medtronic launched OsteoCool RF Ablation System to treat spine metastases, in January 2021. The system destroys cancer cells by using high frequency energy, and also provides procedural flexibility and tailored treatment for spine metastases. However, cost of the tumor treatment is relatively expensive which may restraint the growth of the market.     
Key features of the study:

This report provides in-depth analysis of tumor ablation devices and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, regulatory scenario, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global tumor ablation devices market based on the following parameters – company overview, financial performance, geographical presence, key developments and strategies, and future plans

Key companies covered as a part of this study include Boston Scientific Corporation, Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Inc., Smith & Nephew Plc., Angiodynamics, HealthTronics, Inc, SonaCare Medical, LLC., Galil Medical Inc., EDAP TMS S.A., Abbott Laboratories, NuVasive, Inc, and Alpinion Medical Systems Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, product improvement, market expansion, and marketing tactics

The global tumor ablation devices market report caters to various stakeholders in this industry including investors, researchers, tumor ablation devices manufacturers, new entrants, and financial analysts.
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the tumor ablation devices market.

Detailed Segmentation:

Global Tumor Ablation Devices Market, By Technology:

Radiofrequency Ablation
Microwave Ablation
Cryoablation
High-Intensity Focused Ultrasound
Laser Interstitial Thermal Ablation
Others

Global Tumor Ablation Devices Market, By Application:

Breast Cancer
Liver Cancer
Prostate Cancer
Lung Cancer
Kidney Cancer
Others

Global Tumor Ablation Devices Market, By End User:

Hospitals
Ambulatory Surgical Centers

Global Tumor Ablation Devices Market, By Geography:

North America

By Country:

U.S.
Canada

By Technology:

Radiofrequency Ablation
Microwave Ablation
Cryoablation
High-Intensity Focused Ultrasound
Laser Interstitial Thermal Ablation
Others

By Application:

Breast Cancer
Liver Cancer
Prostate Cancer
Lung Cancer
Kidney Cancer
Others

By End User:

Hospitals
Ambulatory Surgical Centers

Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Technology:

Radiofrequency Ablation
Microwave Ablation
Cryoablation
High-Intensity Focused Ultrasound
Laser Interstitial Thermal Ablation
Others

By Application:

Breast Cancer
Liver Cancer
Prostate Cancer
Lung Cancer
Kidney Cancer
Others

By End User:

Hospitals
Ambulatory Surgical Centers

Asia Pacific

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

By Technology:

Radiofrequency Ablation
Microwave Ablation
Cryoablation
High-Intensity Focused Ultrasound
Laser Interstitial Thermal Ablation
Others

By Application:

Breast Cancer
Liver Cancer
Prostate Cancer
Lung Cancer
Kidney Cancer
Others

By End User:

Hospitals
Ambulatory Surgical Centers

Latin America

By Country:

Brazil
Mexico
Rest of Latin America

By Technology:

Radiofrequency Ablation
Microwave Ablation
Cryoablation
High-Intensity Focused Ultrasound
Laser Interstitial Thermal Ablation
Others

By Application:

Breast Cancer
Liver Cancer
Prostate Cancer
Lung Cancer
Kidney Cancer
Others

By End User:

Hospitals
Ambulatory Surgical Centers  

Middle East

By Country:

GCC
Israel
Rest of Middle East

By Technology:

Radiofrequency Ablation
Microwave Ablation
Cryoablation
High-Intensity Focused Ultrasound
Laser Interstitial Thermal Ablation
Others

By Application:

Breast Cancer
Liver Cancer
Prostate Cancer
Lung Cancer
Kidney Cancer
Others

By End User:

Hospitals
Ambulatory Surgical Centers

Africa

By Country:

North Africa
Central Africa
South Africa

By Technology:

Radiofrequency Ablation
Microwave Ablation
Cryoablation
High-Intensity Focused Ultrasound
Laser Interstitial Thermal Ablation
Others

By Application:

Breast Cancer
Liver Cancer
Prostate Cancer
Lung Cancer
Kidney Cancer
Others

By End User:

Hospitals
Ambulatory Surgical Centers  

Company Profiles

Boston Scientific Corporation*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

Medtronic Plc
Intuitive Surgical, Inc
Johnson & Johnson, Inc
Smith & Nephew Plc
Angiodynamics
HealthTronics, Inc
SonaCare Medical, LLC
Galil Medical Inc.
EDAP TMS S.A
Abbott Laboratories
NuVasive, Inc
Alpinion Medical Systems Co., Ltd.

 “*” marked represents similar segmentation in other categories in the respective section.